American Journal of Hematology · 1999 · 27 citations · 6 references
MedicineHematologyImmunologyClinical ImmunologyImmunotherapyTransfusion MedicineBlood Transfusion ManagementRed Blood Cell TransfusionRh AlloimmunizationImmune Globulin TherapyIntramuscular Injection TechniqueRed Blood Cell Transfusion SafetyRh Alloimmunization ProphylaxisRh D AlloimmunizationTransfusion Reaction Prevention
Alloimmunization to the D blood group antigen following the transfusion of D-positive red blood cells to a D-negative recipient may be prevented in most persons by a prompt and adequate dose of Rho (D) immune globulin (RhIG). Until recently, the only RhIG approved by the US Food and Drug Administration (FDA) for this indication required intramuscular injection, an inconvenient and painful route for the relatively large volume that may be required. We describe the successful prevention of Rh alloimmunization following the unintentional transfusion of D-positive red blood cells to a D-negative infant by the intravenous infusion of WinRho SD, a new RhIG that is FDA-approved for prevention of post-transfusion Rh alloimmunization by intravenous administration. We believe that this more convenient and less painful approach should be the treatment of choice for preventing Rh alloimmunization following the transfusion of D-positive red cells to a D-negative recipient.
6
Blood Transfusion in Clinical Medicine.
JAMA · 1952 · 1.3K citations
Blood Transfusion in Clinical Medicine.
Peter J. Hamilton · PubMed Central · 1998 · 300 citations · Full text
William Pollack, W. Q. Ascari, Richard Kochesky et al. · Transfusion · 1971 · 157 citations
Medicine, Hematology, Immunology +14
William Pollack, W. Q. Ascari, J. F. Crispen et al. · Transfusion · 1971 · 138 citations
Medicine, Hematology, Immunology +14